This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Lonza Ag. Active years: 2004-2015.
Location History:
- Schweiz, CH (2004)
- Spiez, CH (2013)
- Visp, CH (2015)
Company Filing History:
Years Active: 2004-2015
Title: Carsten Meininghaus: Innovator in Peptide Synthesis
Introduction
Carsten Meininghaus is a notable inventor based in Visp, Switzerland. He has made significant contributions to the field of peptide synthesis, particularly in the development of glucagon-like peptides. With a total of 3 patents to his name, Meininghaus continues to push the boundaries of innovation in biochemistry.
Latest Patents
One of his latest patents includes a new method for synthesizing the GLP-1 peptide, which is crucial for diabetes treatment. This innovative approach enhances the efficiency and effectiveness of peptide synthesis, showcasing his commitment to advancing medical science.
Career Highlights
Carsten Meininghaus is currently employed at Lonza AG, a leading global supplier to the pharmaceutical and biotechnology industries. His work at Lonza AG has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Meininghaus has worked alongside talented colleagues such as Oleg Werbitzky and Stéphane Varray. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in peptide synthesis.
Conclusion
Carsten Meininghaus is a distinguished inventor whose work in peptide synthesis has the potential to impact the medical field significantly. His innovative methods and collaborations continue to pave the way for future advancements in biochemistry.